Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury

EMBO Molecular Medicine

Volumn 6, Issue 3, 2014, Pages 384-397

  Bhattacharya, Sabyasachi ^a   Katlinski, Kanstantsin V ^a   Reichert, Maximilian ^b,c   Takano, Shigetsugu ^b,c   Brice, Angela ^a   Zhao, Bin ^a   Yu, Qiujing ^a   Zheng, Hui ^a   Carbone, Christopher J ^a   Katlinskaya, Yuliya V ^a   Leu, N Adrian ^a   Mccorkell, Kelly A ^a   Srinivasan, Satish ^a   Girondo, Melanie ^d   Rui, Hallgeir ^d   May, Michael J ^a   Avadhani, Narayan G ^a   Rustgi, Anil K ^b,c   Fuchs, Serge Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Hepatitis; Inflammation; Interferon; Pancreatitis; Receptor

Indexed keywords

IFNAR 1 RECEPTOR; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE HEPATITIS; BONE MARROW; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EMBRYO; FEMALE; GENE TARGETING; GENETIC SUSCEPTIBILITY; INFLAMMATION; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE INJURY; TISSUE REGENERATION; TOXIC HEPATITIS; UBIQUITINATION; WILD TYPE;

ACUTE DISEASE; ANIMALS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; DRUG-INDUCED LIVER INJURY; FEMALE; GENE KNOCK-IN TECHNIQUES; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIVER; MICE; MICE, INBRED C57BL; PANCREAS; PANCREATITIS; RECEPTOR, INTERFERON ALPHA-BETA; REGENERATION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION;

EID: 84896722537     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201303236     Document Type: Article

References (71)

1. Aman MJ, Tretter T, Eisenbeis I, Bug G, Decker T, Aulitzky WE, Tilg H, Huber C, Peschel C (1996) Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 87: 4731-4736
2. Bernal W, Auzinger G, Dhawan A, Wendon J (2010) Acute liver failure. Lancet 376: 190-201
3. Bhattacharya S, HuangFu WC, Liu J, Veeranki S, Baker DP, Koumenis C, Diehl JA, Fuchs SY (2010) Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 285: 2318-2325
4. Bhattacharya S, Qian J, Tzimas C, Baker DP, Koumenis C, Diehl JA, Fuchs SY (2011) Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 286: 22069-22076
5. Buttmann M, Berberich-Siebelt F, Serfling E, Rieckmann P (2007) Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells. J Vasc Res 44: 51-60
6. Chiu TT, Leung WY, Moyer MP, Strieter RM, Rozengurt E (2007) Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-kappaB. Am J Physiol Cell Physiol 292: C767-C777
7. Coccia EM, Uze G, Pellegrini S (2006) Negative regulation of type I interferon signaling: facts and mechanisms. Cell Mol Biol (Noisy-le-grand) 52: 77-87
8. Du Z, Wei L, Murti A, Pfeffer SR, Fan M, Yang CH, Pfeffer LM (2007) Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J Cell Biochem 102: 1087-1094
9. Dusheiko G (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26: 112S-121S
10. Fan H, Zingarelli B, Harris V, Tempel GE, Halushka PV, Cook JA (2008) Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways. Mol Med 14: 422-428
11. Fuchs SY (2013) Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res 33: 211-225
12. Graler MH, Goetzl EJ (2002) Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 1582: 168-174
13. Guha M, Mackman N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94
14. Hayashi H, Kohno T, Yasui K, Murota H, Kimura T, Duncan GS, Nakashima T, Yamamoto K, Katayama I, Ma Y et al (2011) Characterization of dsRNA-induced pancreatitis model reveals the regulatory role of IFN regulatory factor 2 (Irf2) in trypsinogen5 gene transcription. Proc Natl Acad Sci USA 108: 18766-18771
15. Huangfu WC, Fuchs SY (2010) Ubiquitination-dependent regulation of signaling receptors in cancer. Genes Cancer 1: 725-734
16. Huangfu WC, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY (2012) Inflammatory signaling compromises cell responses to interferon alpha. Oncogene 31: 161-172
17. Jacoby E, Bouhelal R, Gerspacher M, Seuwen K (2006) The 7 TM G-protein-coupled receptor target family. ChemMedChem 1: 761-782
18. Jaitin DA, Roisman LC, Jaks E, Gavutis M, Piehler J, Van der Heyden J, Uze G, Schreiber G (2006) Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol Cell Biol 26: 1888-1897
19. Kalie E, Jaitin DA, Abramovich R, Schreiber G (2007) An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities. J Biol Chem 282: 11602-11611
20. Karaghiosoff M, Steinborn R, Kovarik P, Kriegshauser G, Baccarini M, Donabauer B, Reichart U, Kolbe T, Bogdan C, Leanderson T et al (2003) Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 4: 471-477
21. Karin M (2005) Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2: 386-390; discussion 394-385
22. Katsoulidis E, Li Y, Mears H, Platanias LC (2005) The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J Interferon Cytokine Res 25: 749-756
23. Kubisch CH, Logsdon CD (2007) Secretagogues differentially activate endoplasmic reticulum stress responses in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 292: G1804-G1812
24. Kuehn R, Lelkes PI, Bloechle C, Niendorf A, Izbicki JR (1999) Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas 18: 96-103
25. Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL et al (2007) Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol 179: 935-950
26. Kumar KG, Krolewski JJ, Fuchs SY (2004) Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 279: 46614-46620
27. Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY (2003) SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J 22: 5480-5490
28. Levin D, Harari D, Schreiber G (2011) Stochastic receptor expression determines cell fate upon interferon treatment. Mol Cell Biol 31: 3252-3266
29. Li HC, Stoicov C, Rogers AB, Houghton J (2006) Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 12: 363-371
30. Li Y, Zhou ZG, Xia QJ, Zhang J, Li HG, Cao GQ, Wang R, Lu YL, Hu TZ (2005) Toll-like receptor 4 detected in exocrine pancreas and the change of expression in cerulein-induced pancreatitis. Pancreas 30: 375-381
31. Liu J, Carvalho LP, Bhattacharya S, Carbone CJ, Kumar KG, Leu NA, Yau PM, Donald RG, Weiss MJ, Baker DP et al (2009a) Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol Cell Biol 29: 6401-6412
32. Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY (2009b) Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 5: 72-83
33. Liu J, Plotnikov A, Banerjee A, Suresh Kumar KG, Ragimbeau J, Marijanovic Z, Baker DP, Pellegrini S, Fuchs SY (2008) Ligand-independent pathway that controls stability of interferon alpha receptor. Biochem Biophys Res Commun 367: 388-393
34. Luster MI, Simeonova PP, Gallucci RM, Bruccoleri A, Blazka ME, Yucesoy B (2001) Role of inflammation in chemical-induced hepatotoxicity. Toxicol Lett 120: 317-321
35. Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S (2006) TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem J 397: 31-38
36. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454: 428-435
37. Mitani Y, Takaoka A, Kim SH, Kato Y, Yokochi T, Tanaka N, Taniguchi T (2001) Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells 6: 631-640
38. Moraga I, Harari D, Schreiber G, Uze G, Pellegrini S (2009) Receptor density is key to the alpha2/beta interferon differential activities. Mol Cell Biol 29: 4778-4787
39. Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140: 871-882
40. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920
41. Ostapowicz G, Lee WM (2000) Acute hepatic failure: a Western perspective. J Gastroenterol Hepatol 15: 480-488
42. Pandol SJ (2006) Acute pancreatitis. Curr Opin Gastroenterol 22: 481-486
43. Pastor CM, Pugin J, Kwak B, Chanson M, Mach F, Hadengue A, Frossard JL (2004) Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia. Crit Care Med 32: 1759-1763
44. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML et al (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92: 3780-3792
45. Piehler J, Thomas C, Christopher Garcia K, Schreiber G (2012) Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev 250: 317-334
46. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386
47. Qian J, Zheng H, Huangfu WC, Liu J, Carbone CJ, Leu NA, Baker DP, Fuchs SY (2011) Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1. PLoS Pathog 7: e1002065
48. Reichert M, Rustgi AK (2011) Pancreatic ductal cells in development, regeneration, and neoplasia. J Clin Invest 121: 4572-4578
49. Reichert M, Takano S, von Burstin J, Kim SB, Lee JS, Ihida-Stansbury K, Hahn C, Heeg S, Schneider G, Rhim AD et al (2013) The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev 27: 288-300
50. Rosenbaum DM, Rasmussen SG, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459: 356-363
51. Roth-Cross JK, Bender SJ, Weiss SR (2008) Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 82: 9829-9838
52. Rudick RA, Ransohoff RM, Peppler R, VanderBrug Medendorp S, Lehmann P, Alam J (1996) Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol 40: 618-627
53. Sharma B, Joshi S, Sassano A, Majchrzak B, Kaur S, Aggarwal P, Nabet B, Bulic M, Stein BL, McMahon B et al (2012) Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses. J Biol Chem 287: 42352-42360
54. Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ et al (2006) Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res 26: 804-819
55. Stark GR, Darnell JE Jr (2012) The JAK-STAT pathway at twenty. Immunity 36: 503-514
56. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264
57. Thomas C, Moraga I, Levin D, Krutzik PO, Podoplelova Y, Trejo A, Lee C, Yarden G, Vleck SE, Glenn JS et al (2011) Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell 146: 621-632
58. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90: 196-203
59. Tilley DG (2011) G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function. Circ Res 109: 217-230
60. Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207: 2053-2063
61. Trivedi CD, Pitchumoni CS (2005) Drug-induced pancreatitis: an update. J Clin Gastroenterol 39: 709-716
62. Ueda T, Takeyama Y, Yasuda T, Matsumura N, Sawa H, Nakajima T, Kuroda Y (2006) Vascular endothelial growth factor increases in serum and protects against the organ injuries in severe acute pancreatitis. J Surg Res 134: 223-230
63. Uze G, Schreiber G, Piehler J, Pellegrini S (2007) The receptor of the type I interferon family. Curr Top Microbiol Immunol 316: 71-95
64. Wang CI, Lewis RJ (2013) Emerging opportunities for allosteric modulation of G-protein coupled receptors. Biochem Pharmacol 85: 153-162
65. de Weerd NA, Vivian JP, Nguyen TK, Mangan NE, Gould JA, Braniff SJ, Zaker-Tabrizi L, Fung KY, Forster SC, Beddoe T et al (2013) Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1. Nat Immunol 14: 901-907
66. Zhang D, Zhang DE (2011) Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res 31: 119-130
67. Zhao J, He D, Su Y, Berdyshev E, Chun J, Natarajan V, Zhao Y (2011) Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. Am J Physiol Lung Cell Mol Physiol 301: L547-L556
68. Zheng H, Qian J, Baker DP, Fuchs SY (2011a) Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J Biol Chem 286: 35733-35741
69. Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs SY (2011b) Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood 118: 4003-4006
70. Zheng H, Qian J, Varghese B, Baker DP, Fuchs S (2011c) Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2. Mol Cell Biol 31: 710-720
71. Zhou X, Liu Z, Jang F, Xiang C, Li Y, He Y (2012) Autocrine Sonic hedgehog attenuates inflammation in cerulein-induced acute pancreatitis in mice via upregulation of IL-10. PLoS One 7: e44121